Haresign Consulting Services

National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Quetiapine Oral Suspension (unlicensed medicine), manufactured by Eaststone Limited due to a potential for overdosing, NatPSA/2026/002/MHRA

Published

29 January 2026

Source

Alerts and Recalls for Drugs and Medical Devices - General Practice

Imported

5 Aug 2026

Original alert

https://www.gov.uk/drug-device-alerts/n…

Eaststone Limited is initiating a recall of all batches of quetiapine oral suspension products due to a potential risk of overdose, which could have consequences for the safety of patients.

View Original Alert

Important: This alert is aggregated automatically for information only. Always refer to the original source and follow your practice's own clinical governance procedures.

About this source

Alerts and Recalls for Drugs and Medical Devices - General Practice

All alerts from this source

Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.

View this week's digest

Back to Safety Alerts

Unlock your Practice Performance Overview

Register your practice for free to bring QOF, workforce, access, finance, contract and CQC data into a single live dashboard — benchmarked to national figures with an at-a-glance health score.